AI Reports · OpenAI · 2026-10-20 · Blog / commentary
OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D. The move aims to help biopharma teams accelerate drug development and advance new treatments.